Social Media Ideas for Boehringer Ingelheim

Boehringer Ingelheim Annual Report 2025

Best Annual Report

Hoechst-Roussel

Hoechst-Roussel Anonymous (not verified) Thu, 07/16/2026 - 12:16 field_thread_url https://cafepharma.com/boards/threads/hoechst-roussel.12347/...

Boehringer Alleges United Therapeutics Poached Staff, Secrets

Boehringer Ingelheim Pharmaceuticals Inc. is suing United Therapeutics Corp. in Delaware Chancery Court, alleging it recruited more than 20 members of Boehringer's specialized inte...

Boehringer places phase 1 study of investigational drug on hold to examine ‘safety event’

Boehringer Ingelheim has suspended a phase 1 trial of an investigational small molecule drug while it seeks to understand a “safety event,” although the German pharma isn't sheddin...

<![CDATA[Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTe...

<![CDATA[ Eli Lilly to Acquire Merida Biosciences for $2.8 Billion ]]>

<![CDATA[Roundup: Amplitude Therapeutics, Chai Discovery Enter Collaborations with Eli Lilly, Bristol Myers Squibb]]&...

<![CDATA[M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to...

<![CDATA[M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration wit...

<![CDATA[Eli Lilly to Acquire AtaiBeckley for $2.8 Billion ]]>

<![CDATA[M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with...

<![CDATA[BeOne Medicines Enters Collaboration with Revolution Medicines for Oncology Therapies ]]>

<![CDATA[Eli Lilly Surpasses Wall Street Estimates on Injectable GLP-1 Drugs]]>

Owkin signs AI drug discovery deal with Boehringer for cancer, immunology

<![CDATA[BioNTech Terminates Phase II Clinical Trial for Cevumeran ]]>

<![CDATA[Pharmaceutical Executive Daily: Hanmi Licenses HM17321 to Genentech]]>

<![CDATA[Mereo BioPharma Enters Option and License Agreement with Sentynl Therapeutics for alvelestat ]]>

Owkin signs AI drug discovery deal with Boehringer for cancer, immunology

<![CDATA[Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321 ]]>

Chutes & Ladders—BioNTech brings in Sobi CEO

After a six-month wait, BioNTech has finally filled its vacant CEO spot with Guido Oelkers, Ph.D. Oelkers hails from his tenure as CEO of Swedish pharma Sobi, where he oversaw the...

<![CDATA[FDA Approves Leqembi Iqlik Subcutaneous Injection for Early Alzheimer’s Disease]]>

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Enters $2.8 Billion Agreement to Acquire Merida Biosciences]]>

Eli Lilly inks $2.88B Merida buyout for autoimmune drugs against rogue antibodies

Eli Lilly has struck a deal to acquire Merida Biosciences for up to $2.875 billion, establishing a beachhead in efforts to treat disease through the selective degradation of pathog...

<![CDATA[argenx Acquires Forte Biosciences for $2.2 Billion]]>